Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Physical Therapy for Migraine With Cervical Dysfunction
NCT05226559Recruiting
- Sponsor
- Neuromed Pharmaceuticals
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms), sponsored by Neuromed Pharmaceuticals. Primary endpoints: Change in monthly migraine days at 28 weeks and Change in monthly migraine days with use of acute medication at 28 weeks. Started Feb 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05226559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05226559.